OTCPicks Featured Company: Immunicon Corporation (IMMC) Awarded Clearance from FDA of CellSearch™ Circulating Tumor Kit
Immunicon Corporation was recently issued clearance by the FDA of the CellSearch™ Circulating Tumor Cell Kit for monitoring patients with metastatic prostate cancer. Using the CellSearch™ kit, samples of a patient's blood is processed to occupy and count CTC's. The company saw a rise of 50.00% as trading began this morning. The kit is now cleared for three of the four most prevalent cancers. Originally cleared in January of 2004, the kit was then predicting progression-free and overall survival in patients with metastatic breast cancer, and expanded after to include monitoring. In November of 2007, the kit was cleared by…